The Aplastic Anaemia Trust
The Aplastic Anaemia Trust is the only UK charity dedicated to aplastic anaemia and related rare bone marrow failure conditions, providing free patient support, emotional wellbeing services, information resources, community events, and research funding to patients, families, and clinicians across the United Kingdom.
- Company typePrivate
- Founded1984
- HeadquartersBirmingham, United Kingdom
- Headcount11–50
- GTM typeB2C
- OfferingServices
What The Aplastic Anaemia Trust does
The Aplastic Anaemia Trust is a UK-registered charity (No. 1107539 in England & Wales, SC049810 in Scotland) founded in 1984 by Ted Gordon-Smith to improve outcomes for people affected by aplastic anaemia and related rare bone marrow failure conditions, including PNH, Fanconi anaemia, Dyskeratosis Congenita, Shwachman Diamond Syndrome, and Diamond Blackfan Anaemia Syndrome. The organisation provides direct patient and family support through a helpline, one-to-one emotional wellbeing sessions with a clinical psychologist, group courses (mindfulness, stress management), community events (Coffee Cake and Chat, walks, half marathons, Santa Splash), webinars, and printed information materials, alongside the MarrowKidz microsite for children and young people and the Rare Voices podcast. It funds and shapes research, notably co-funding the world-first TIARA cell therapy clinical trial at King's College Hospital with LifeArc, and convenes a Research and Clinical Advisory Panel of senior haematologists to set clinical care and research priorities.
The Trust operates a non-commercial model: all patient-facing services are free, and income is generated through individual donations, community fundraising events, merchandise sales, conference sponsorship from pharmaceutical companies (including Alexion AstraZeneca, Pfizer, Roche, and Sobi for the 2024 research conference), named research funds, and co-funded research grants. Underlying technology is intentionally lightweight — a website platform and the ThankQ CRM by Access Group — with no proprietary technology product; the primary 'technology' of the Trust is its human clinical expertise, its 40-year content library, and its patient community, which together serve an estimated 39% of newly diagnosed UK patients each year. The organisation is led by CEO Joe Kirwin and Deputy CEO Ellie Dawes, is governed by a Board of Trustees, and is currently running an active 'Access to Eltrombopag' advocacy campaign alongside expansion of its wellbeing services and a recently launched patient registration system.
The Aplastic Anaemia Trust firmographics
Firmographics- Name
- The Aplastic Anaemia Trust
- Legal name
- The Aplastic Anaemia Trust
- Website
- https://theaat.org.uk
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- The Aplastic Anaemia Trust is the only UK charity dedicated to aplastic anaemia and related rare bone marrow failure conditions, providing free patient support, emotional wellbeing services, information resources, community events, and research funding to patients, families, and clinicians across the United Kingdom.
- Ownership category
- akta.pro rank
The Aplastic Anaemia Trust industry classification
Industry- Product category
- Patient Advocacy and Rare Disease Support Services
- NAICS
- Individual and Family Services (6241), Voluntary Health Organizations (813212)
- SIC
- Services-Social Services (8300), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Rare Disease & Special Needs Support Organizations (BPAGACAM)
- akta.pro secondary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
Keywords
Where The Aplastic Anaemia Trust is headquartered
LocationHeadquarters
- HQ city
- Birmingham
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
The Aplastic Anaemia Trust business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales
Revenue model
- Donations and Fundraising: The charity receives donations from individuals, families, and supporters. They organize fundraising events including walks, half marathons, Santa Splash events, and corporate donations.
- Conference Sponsorship: Pharmaceutical companies including Alexion AstraZeneca, Pfizer, Roche, and Sobi sponsored their 2024 research conference. Sponsorship revenue supports research and operational activities.
- Merchandise Sales: The charity operates an online shop selling branded merchandise including items purchased through their e-commerce platform.
- Shop Sales: Sale of printed leaflets, booklets, and information materials for children and adults affected by aplastic anaemia.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | Free Support Services |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels9 records
The Aplastic Anaemia Trust product offering
Product offeringCore offering
The Aplastic Anaemia Trust provides free patient support services, information resources, and emotional wellbeing programs for individuals affected by aplastic anaemia and related rare bone marrow failure conditions. The charity also funds medical research, including the world-first TIARA clinical trial, and conducts advocacy campaigns for treatment access. Core offerings include a support helpline, the MarrowKidz children's microsite, online courses, podcasts, printed materials, and community events across the UK.
Product overview
The Aplastic Anaemia Trust offers a portfolio of support services and information resources for people affected by aplastic anaemia and related rare bone marrow failure conditions. The core offerings include: a helpline for direct support; MarrowKidz (a dedicated children's microsite); Emotional Wellbeing Support (one-to-one sessions, online courses, and group events); the Rare Voices podcast; patient stories blog; an A-Z medical jargon buster; and printed information materials. The charity focuses on patient support, education, and community connection rather than a technology product.
Differentiator
Problem solved
Functional benefit
Brands
- MarrowKidz: A dedicated microsite providing resources and guides specifically designed for children and young people who have aplastic anaemia, or who are supporting a family member with the condition.
Products and services
- Emotional Wellbeing Support Free emotional and psychological support services for people with rare bone marrow failure conditions, including one-to-one support, online courses, monthly group sessions with a Clinical Psychologist, and in-person Coffee Cake and Chat events at treatment locations.
- MarrowKidz
- Rare Voices Podcast
- Helpline Support
- Patient Registration Registration service for people living with aplastic anaemia or related conditions (PNH, Fanconi anaemia, Dyskeratosis Congenita, Shwachman Diamond Syndrome) to connect with the charity and receive support.
- Online Courses
- Support Events
- Printed Information Materials
- Patient Stories (AA Voices)
- A-Z Jargon Buster
Quantifiable outcome
- 39% of newly diagnosed patients in the UK have been in direct contact with the trust
- +2 more outcomes
Companies that use The Aplastic Anaemia Trust
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
The Aplastic Anaemia Trust technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
The Aplastic Anaemia Trust partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered minor and core.
- London Wildlife TrustminorPartnership to organize accessible outdoor community events for people affected by aplastic anaemia. They co-hosted the London Wildlife Walk at Walthamstow Wetlands, providing nature experiences and peer connection opportunities.
- Clinical Psychologist (Lesley)coreExpert Clinical Psychologist specializing in supporting people managing complex physical health conditions. Works with the support team to provide appropriate levels of emotional wellbeing support to patients.
- Sami FitzminorCreated a relaxing Sound Bath recording to help members of the community unwind after difficult days.
- Becky (Present Moment Meditation)minorProduced a starry night meditation recording to aid sleep for members of the aplastic anaemia community.
- Bethan EcclestoneminorQualified yoga practitioner who created a yoga session designed for the aplastic anaemia community, suitable for varying mobility levels.
- Caroline LovettminorPsychosexual and relationship therapist who worked with the trust to create articles and videos about sex and relationships for people living with rare bone marrow failure conditions.
- Clarise PattisonminorMindfulness practitioner leading eight-week series of group sessions offering mindfulness-based approaches to managing stress related to the condition.
- Research and Clinical Advisory Panel (RCAP)coreExpert panel including Professor Ghulam Mufti OBE, Professor Rod Skinner, Professor Alan Warren, Dr Austin Kulasekararaj, Dr Bethany Mitchell, Callum Tempest, Dr David Irvine, Professor John Snowden, Professor Josu de la Fuente, Dr Keith Wilson, Dr Morag Griffin, Dr Sanjay Tewari, and Dr Sujith Samarasinghe providing clinical and research guidance.
- Maggie's CentreminorCancer support center that provides resources and support spaces near hospitals, mentioned in patient stories as part of the care ecosystem.
- NHSminorPartnership to add aplastic anaemia content to NHS Inform, the NHS website for Scotland, providing authoritative health information to patients.
- King's College Hospital and King's College LondoncoreLeading research institutions conducting the TIARA clinical trial, a world-first cell therapy treatment for aplastic anaemia, funded by The Aplastic Anaemia Trust and LifeArc.
- MyIntent (Bequeathed)minorTrusted partner providing a free Will writing service for supporters of The Aplastic Anaemia Trust.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
The Aplastic Anaemia Trust competitors and assessment
Company assessmentBroad incumbents
- Blood Cancer UK: Major UK blood cancer charity with a research-funding and patient-support mandate. Comparable in mission and UK footprint but operates at a much broader disease scope than aplastic anaemia specifically.
- Genetic Alliance UK: UK umbrella alliance for over 200 rare disease patient organizations. Comparable as a coordinating body for rare disease advocacy and policy engagement, including conditions the trust covers.
- Macmillan Cancer Support: Large UK charity providing information, emotional support, and financial guidance to people affected by cancer, including those undergoing bone marrow transplant. Comparable support-services infrastructure at much larger scale.
- Rare Disease UK: UK national campaign for rare diseases run by Genetic Alliance UK. Comparable in patient advocacy and policy focus for the rare disease community that includes aplastic anaemia patients.
- DKMS: International blood stem cell donor registry active in the UK, with overlap in bone marrow failure and transplant patient pathways. Comparable as a major registry and patient support actor in the same disease space.
Others
- LifeArc: UK medical research charity that co-funds the TIARA clinical trial with The Aplastic Anaemia Trust. Not a competitor but a directly adjacent research-funding partner and ecosystem peer in rare disease translation.
Direct peers
- Anthony Nolan: UK charity focused on stem cell and bone marrow transplantation, including aplastic anaemia. Highly comparable as a UK-based rare bone marrow failure support and patient recruitment organization.
- MDS UK Patient Support Group: UK charity supporting patients with Myelodysplastic Syndromes, an adjacent bone marrow failure condition. Directly comparable support-services and patient-advocacy model for UK rare blood disorder patients.
- PNH Support: UK-specific charity for Paroxysmal Nocturnal Haemoglobinuria (PNH), one of the related conditions served by The Aplastic Anaemia Trust. Directly comparable patient advocacy and support model.
- Fanconi Hope: UK charity dedicated to Fanconi Anaemia — one of the rare inherited bone marrow failure conditions covered by the trust. Direct niche peer serving the same patient subset.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
The Aplastic Anaemia Trust social profiles
Digital presenceThe Aplastic Anaemia Trust financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Aplastic Anaemia Trust leadership team
Management profileNumber of profiles
Profiles4 records
The Aplastic Anaemia Trust funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Aplastic Anaemia Trust M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Aplastic Anaemia Trust
What does The Aplastic Anaemia Trust do?
The Aplastic Anaemia Trust provides free patient support services, information resources, and emotional wellbeing programs for individuals affected by aplastic anaemia and related rare bone marrow failure conditions. The charity also funds medical research, including the world-first TIARA clinical trial, and conducts advocacy campaigns for treatment access. Core offerings include a support helpline, the MarrowKidz children's microsite, online courses, podcasts, printed materials, and community events across the UK.
Is The Aplastic Anaemia Trust a public or private company?
The Aplastic Anaemia Trust is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Aplastic Anaemia Trust founded?
The Aplastic Anaemia Trust was founded in 1984. It employs 11 to 50 people.
Where is The Aplastic Anaemia Trust based?
The Aplastic Anaemia Trust is headquartered in Birmingham, United Kingdom, in the Europe region.
How does The Aplastic Anaemia Trust make money?
Four revenue lines are on record. Donations and Fundraising is the primary driver. The others are conference Sponsorship, merchandise Sales and shop Sales.
Who are The Aplastic Anaemia Trust's main competitors?
Broad incumbents on record are Blood Cancer UK, Genetic Alliance UK, Macmillan Cancer Support, Rare Disease UK and DKMS. LifeArc is listed as an others. Direct peers are Anthony Nolan, MDS UK Patient Support Group, PNH Support and Fanconi Hope.
Does The Aplastic Anaemia Trust have an API?
No public API is recorded for The Aplastic Anaemia Trust.
What industry is The Aplastic Anaemia Trust in?
The Aplastic Anaemia Trust's product category is Patient Advocacy and Rare Disease Support Services. Its primary akta.pro industry code is BPAGACAM, Rare Disease & Special Needs Support Organizations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 6241 and its SIC code is 8300.